Mirum gets FDA approval for rare bone disorder drug
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Health & Medicine
Kenya Tobacco Bill faces fresh clash over licences, nicotine ban
Kenya’s proposed Tobacco Control (Amendment) Bill has triggered competing demands from tobacco traders, farmers, regulators and consumers, exposing sharp differences over new licensing requirements…
FDA approves Mirum’s drug for ultra-rare soft tissue disease
The FDA has approved the third treatment for a debilitating genetic disease that turns muscle and connective tissue to bone.
H5N1 could be high-risk pandemic source — Imperial expert
The highly pathogenic H5N1 avian influenza virus could pose a high risk as a source of a future pandemic, as its spread across birds and mammals continues to expand, a leading infectious disease…
Did FDA Advisors Support a Cancer Early-Detection Blood Test?
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
What is kratom, the 'gas station heroin' alarming officials in the US?
Kratom, found during an investigation into the deaths of two college students, has been sold in the US for around a decade.
Why Are Americans Dying Younger? Study Uncovers Several Surprising Causes
America ranks 38th for life expectancy. A new study shows the surprising diseases driving rising deaths.